High Pointe Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$2.81M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$2.75M |
| 3 |
FedEx
FDX
|
+$2.41M |
| 4 |
Cigna
CI
|
+$1.95M |
| 5 |
Exelon
EXC
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$2.29M |
| 2 |
Johnson & Johnson
JNJ
|
+$1.93M |
| 3 |
FMC
FMC
|
+$1.37M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$599K |
| 5 |
Microsoft
MSFT
|
+$444K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.03% |
| 2 | Financials | 16.75% |
| 3 | Materials | 12.4% |
| 4 | Technology | 10.89% |
| 5 | Communication Services | 9.77% |
Similar funds
High Pointe Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, High Pointe Capital Management held 97 positions worth $150M, up 19% from $126M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
High Pointe Capital Management deployed $14.8M of net new capital in Q4 2021, opening 5 new positions and adding to 43 existing holdings. Its largest new stake was Elanco Animal Health: 90,290 shares worth $2.56M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.93M trimmed.
- High Pointe Capital Management's largest Q4 2021 buy was Elanco Animal Health: 90,290 shares worth $2.56M.
- High Pointe Capital Management added most to Exelon in Q4 2021, an estimated $1.19M increase.
- High Pointe Capital Management's biggest Q4 2021 reduction was Johnson & Johnson, cutting an estimated $1.93M.
- High Pointe Capital Management fully exited Aon in Q4 2021, selling an estimated $2.29M.
- High Pointe Capital Management's ten largest holdings make up 24% of its $150M portfolio in Q4 2021.
- High Pointe Capital Management opened 5 new positions and closed 7 in Q4 2021.
- High Pointe Capital Management's portfolio value rose 19% quarter-over-quarter to $150M.
Based on High Pointe Capital Management's 13F filing for Q4 2021, filed 8 Feb 2022.